BiondVax Announces First Quarter 2022 Financial Results and Provides Business Update

JERUSALEM, June 1, 2022 /PRNewswire/ —  BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV), a biopharmaceuticals company focused on developing, manufacturing and commercializing innovative products for the prevention and treatment of infectious diseases…

Luminar Provides Business Update and Q1 2022 Financials

Accelerating Business Growth and On-Track for All Four Key 2022 Milestones and Financial Guidance ORLANDO, Fla., May 05, 2022–(BUSINESS WIRE)–Luminar (NASDAQ: LAZR), a leading global automotive technology company, today announced…